Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01020968 · ClinicalTrials.gov registry record · Phase 2

Use of Ixmyelocel-T (Formerly Catheter-based Cardiac Repair Cell [CRC]) Treatment in Patients With Heart Failure Due to Dilated Cardiomyopathy

A Phase 2 study of Dilated Cardiomyopathy, sponsored by Vericel Corporation.

Completed
Registry status
Phase 2
Development phase
22
Enrollment target
3
Study locations

NCT01020968 is a Phase 2 study of Dilated Cardiomyopathy that has completed, run by Vericel Corporation. The registered enrollment target is 22 participants, below the 259-participant average among 6 other Dilated Cardiomyopathy trials with a reported enrollment target (92% lower). The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01020968, a Phase 2 study of Dilated Cardiomyopathy, has completed, sponsored by Vericel Corporation.

COMPLETED
Registry status
Phase 2
Development phase
22 participants
Enrollment target
3
Study locations

Study Summary

This study is designed to assess the safety profile and the efficacy of cardiac repair cells (CRCs) administered via catheter in treating patients with dilated cardiomyopathy (DCM).

Conditions Studied

Dilated Cardiomyopathy

Interventions

  • OTHER Vehicle Control
  • BIOLOGICAL Ixmyelocel-T

Study Locations (3)

Minnesota

  • Minneapolis Heart Institute - Minneapolis

Ohio

  • University Hospitals, Case Western Reserve University - Cleveland

Utah

  • University of Utah - Salt Lake City

Trial Details

FieldValue
Enrollment Target 22 participants
Start Date 2009-12
Est. Completion 2013-12-05
Phase Phase 2

Sponsor

Vericel Corporation

11 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01020968

The ClinicalTrials.gov registry entry for NCT01020968 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 259-participant average among 6 other Dilated Cardiomyopathy trials with a reported enrollment target (92% lower). The listed sponsor is Vericel Corporation, which has 11 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Dilated Cardiomyopathy appearing as the primary indexed condition, and to 2 interventions - of which Vehicle Control is the first listed.

NCT01020968 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Minnesota, Ohio, Utah.

Frequently Asked Questions

What is clinical trial NCT01020968 about?

NCT01020968 is a clinical study titled "Use of Ixmyelocel-T (Formerly Catheter-based Cardiac Repair Cell [CRC]) Treatment in Patients With Heart Failure Due to Dilated Cardiomyopathy". This study is designed to assess the safety profile and the efficacy of cardiac repair cells (CRCs) administered via catheter in treating patients with dilated cardiomyopathy (DCM).

What is the current status of trial NCT01020968?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 22 participants. The study started on 2009-12. Estimated completion is 2013-12-05.

What conditions does trial NCT01020968 study?

This clinical trial studies the following conditions: Dilated Cardiomyopathy.

What interventions are being tested in trial NCT01020968?

The interventions under investigation include: Vehicle Control (OTHER), Ixmyelocel-T (BIOLOGICAL).

Who is sponsoring clinical trial NCT01020968?

This trial is sponsored by Vericel Corporation, which has 11 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01020968 being conducted?

This trial has 3 study locations across Minnesota, Ohio, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Dilated Cardiomyopathy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Dilated Cardiomyopathy

All registered trials for this condition

Minnesota

All trials with a study site in Minnesota

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.